Copenhagen Phase IV Unit (Phase4CPH) was initiated in 2018 by the Capital Region in close collaboration between Department of Clinical Pharmacology and Center for Clinical Research and Prevention at Bispebjerg and Frederiksberg Hospital in the Capital Region.  

The ambition of Phase4CPH is to conduct and develop phase IV pharmacoepidemiological studies of clinical importance, using state-of-the art methods and contribute to innovation in the field. We want to develop and optimize private-public partnerships on real life studies, and interact with academia on development of new methods and education within pharmacoepidemiology.